Results 51 to 60 of about 625,107 (192)
This article is a hermeneutic work about the author's loss of her cousin to childhood cancer and the poetic reflection that arises when one gives oneself over to writing about it.
Jodi Latremouille
doaj +1 more source
Type of cancer diagnosed and the treatment modalities for participants admitted at a paediatric oncology unit.
Ndapewa Ottilie Kaholongo (17404066) +1 more
core +1 more source
Physical activity (PA) plays a critical role in supporting recovery and improving overall health outcomes in paediatric oncology patients, who commonly experience cancer and treatment related side effects such as fatigue, reduced muscle strength ...
Greta Franceska Jermolenko +10 more
doaj +1 more source
PROPTOSIS IN ACUTE MYELOID LEUKEMIA: AN UNDER RECOGNIZED PRESENTATION OF HEMATOLOGICAL MALIGNANCY
OBJECTIVE: To determine the frequency of proptosis and associations of proptosis with demographic, clinical and hematological characteristics with acute myeloid leukemia (AML) in children.
Tanzeela Farah +4 more
doaj +1 more source
European standard clinical practice recommendations for children and adolescents with Rhabdomyosarcoma a joint EpSSG, CWS and ERN PaedCan project [PDF]
Rhabdomyosarcoma; Treatment recommendations; Pediatric oncologyRabdomiosarcoma; Recomendaciones de tratamiento; Oncología pediátricaRabdomiosarcoma; Recomanacions de tractament; Oncologia pediàtricaRhabdomyosarcoma (RMS) is a heterogeneous group of ...
Ebinger, Martin +6 more
core +1 more source
Use Cases Requiring Privacy-Preserving Record Linkage in Paediatric Oncology. [PDF]
Large datasets in paediatric oncology are inherently rare. Therefore, it is paramount to fully exploit all available data, which are distributed over several resources, including biomaterials, images, clinical trials, and registries.
Hayn D +10 more
europepmc +3 more sources
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating ...
Janczar, Szymon +39 more
core +1 more source
Patient-reported outcomes (PROs) enable the report of experiences that are only known to the patient, such as how an individual’s symptoms, functioning, and quality of life are impacted by a health condition or treatment. The choice of PRO depends on the
Ameeta Retzer +9 more
doaj +1 more source
SIOPEL trials using preoperative chemotherapy in hepatoblastoma.
Hepatoblastoma is a rare, malignant liver tumour of childhood. Until the mid 1980s only around 30% of patients were cured, but with modern chemotherapy, and of course surgery, the cure rate is now at least 70%.
PERILONGO, GIORGIO +3 more
core
Pediatric Cardio-Oncology: From Gap in Evidence to Future Perspectives
Improved survival rates for paediatric cancer patients represent a major medical achievement, but they have simultaneously brought the long-term sequelae of oncological treatments into sharp focus.
Adriana Correra +8 more
doaj +1 more source

